Light Chain Bioscience Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Private

  • Employees
  • 81

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 12

  • Investments
  • 1

Light Chain Bioscience General Information

Description

Operator of a biopharmaceutical company intended to discover multispecific antibody-based drugs. The company is focused on the development of drugs that are targeted for the treatment of inflammatory diseases, immune-related disorders, and cancer, enabling patients to get advanced treatment for their diseases and get cured efficiently.

Contact Information

Formerly Known As
NovImmune
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • 15B Chemin du Pré-Fleuri
  • Plan-Les-Ouates
  • 1228 Geneva
  • Switzerland
+41 022
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 15B Chemin du Pré-Fleuri
  • Plan-Les-Ouates
  • 1228 Geneva
  • Switzerland
+41 022

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Light Chain Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Light Chain Bioscience‘s full profile, request access.

Request a free trial

Light Chain Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to discover multispecific antibody-based drugs. The company is focused
Drug Discovery
Geneva, Switzerland
81 As of 2025

Plymouth Meeting, PA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Light Chain Bioscience Competitors (52)

One of Light Chain Bioscience’s 52 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Immunocore Holdings Formerly VC-backed Abingdon, United Kingdom
Virometix Venture Capital-Backed Schlieren, Switzerland
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 52 competitors. Get the full list »

Light Chain Bioscience Patents

Light Chain Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026082966-A1 Methods of treating disease using anti-cd47 x anti-mesothelin antibodies in combination with chemotherapy Pending 18-Oct-2024
WO-2026078067-A1 Fcrh5 monospecific antibodies and derived fcrh5xcd28 bispecific antibodies and use thereof Pending 08-Oct-2024
AU-2024391478-A1 Method of treating disease using anti-cd47 x anti-mesothelin antibodies as a sole agent and in combination with anti-pd-1 antibodies Pending 28-Nov-2023
EP-4815980-A1 Method of treating disease using anti-cd47 x anti-mesothelin antibodies as a sole agent and in combination with anti-pd-1 antibodies Pending 28-Nov-2023
US-20250171537-A1 Method of treating disease using anti-cd47 x anti-mesothelin antibodies as a sole agent and in combination with anti-pd-1 antibodies Pending 28-Nov-2023 C07K16/2803
To view Light Chain Bioscience’s complete patent history, request access »

Light Chain Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Light Chain Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Light Chain Bioscience‘s full profile, request access.

Request a free trial

Light Chain Bioscience Investments (1)

Light Chain Bioscience’s most recent deal was a Corporate Asset Purchase with Novimmune (TZLS-501, A Fully Human Monoclonal Antibody). The deal was made on 01-Jan-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novimmune (TZLS-501, A Fully Human Monoclonal Antibody) 01-Jan-2017 Corporate Asset Purchase Buildings and Property
To view Light Chain Bioscience’s complete investments history, request access »

Light Chain Bioscience FAQs

  • When was Light Chain Bioscience founded?

    Light Chain Bioscience was founded in 1998.

  • Where is Light Chain Bioscience headquartered?

    Light Chain Bioscience is headquartered in Geneva, Switzerland.

  • What is the size of Light Chain Bioscience?

    Light Chain Bioscience has 81 total employees.

  • What industry is Light Chain Bioscience in?

    Light Chain Bioscience’s primary industry is Drug Discovery.

  • Is Light Chain Bioscience a private or public company?

    Light Chain Bioscience is a Private company.

  • What is Light Chain Bioscience’s current revenue?

    The current revenue for Light Chain Bioscience is .

  • How much funding has Light Chain Bioscience raised over time?

    Light Chain Bioscience has raised $235M.

  • Who are Light Chain Bioscience’s investors?

    Deutsche Messe and University of Geneva have invested in Light Chain Bioscience.

  • Who are Light Chain Bioscience’s competitors?

    Inovio Pharmaceuticals, CytomX Therapeutics, Immunocore Holdings, Virometix, and Adaptimmune Therapeutics are some of the 52 competitors of Light Chain Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process